Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15.4M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
4.36M
-
Shares change
-
-177K
-
Total reported value, excl. options
-
$43M
-
Value change
-
-$1.87M
-
Number of buys
-
18
-
Number of sells
-
-19
-
Price
-
$9.87
Significant Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q1 2016
48 filings reported holding GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value as of Q1 2016.
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.36M shares
of 15.4M outstanding shares and own 28.22% of the company stock.
Largest 10 shareholders include Karpus Management, Inc. (998K shares), First Allied Advisory Services, Inc. (608K shares), MORGAN STANLEY (543K shares), RAYMOND JAMES & ASSOCIATES (420K shares), Thomas J. Herzfeld Advisors, Inc. (290K shares), GAMCO INVESTORS, INC. ET AL (217K shares), ROYAL BANK OF CANADA (211K shares), WELLS FARGO & COMPANY/MN (174K shares), CITIGROUP INC (99.4K shares), and MetLife Securities, Inc (92.7K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.